AC8.AX
Auscann Group Holdings Ltd
Price:  
0.04 
AUD
Volume:  
189,555.00
Australia | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AC8.AX Intrinsic Value

-3,545.80 %
Upside

What is the intrinsic value of AC8.AX?

As of 2026-05-26, the Intrinsic Value of Auscann Group Holdings Ltd (AC8.AX) is (1.38) AUD. This AC8.AX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.04 AUD, the upside of Auscann Group Holdings Ltd is -3,545.80%.

The range of the Intrinsic Value is (9.86) - (0.76) AUD

Is AC8.AX undervalued or overvalued?

Based on its market price of 0.04 AUD and our intrinsic valuation, Auscann Group Holdings Ltd (AC8.AX) is overvalued by 3,545.80%.

Note: result may not be accurate due to the invalid valuation result of DCF model.

0.04 AUD
Stock Price
(1.38) AUD
Intrinsic Value
Intrinsic Value Details

AC8.AX Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (9.86) - (0.76) (1.38) -3545.8%
DCF (Growth 10y) (0.83) - (10.05) (1.46) -3743.5%
DCF (EBITDA 5y) (0.21) - (0.26) (1,234.50) -123450.0%
DCF (EBITDA 10y) (0.30) - (0.36) (1,234.50) -123450.0%
Fair Value -0.11 - -0.11 -0.11 -374.07%
P/E (0.46) - (0.40) (0.42) -1149.7%
EV/EBITDA (0.20) - (0.20) (0.21) -627.9%
EPV (0.21) - (0.28) (0.25) -716.2%
DDM - Stable (0.24) - (1.15) (0.70) -1840.3%
DDM - Multi (0.25) - (0.96) (0.40) -1103.5%

AC8.AX Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 17.62
Beta 0.88
Outstanding shares (mil) 440.55
Enterprise Value (mil) 13.97
Market risk premium 5.10%
Cost of Equity 7.91%
Cost of Debt 5.00%
WACC 5.71%